Incoming president and CEO Peter Arduini laid out a path towards an agile future that exploits the ‘power of lean’ for GE Healthcare, ahead of the division’s 2023 spin off as a separate company.

Incoming president and CEO Peter Arduini laid out a path towards an agile future that exploits the ‘power of lean’ for GE Healthcare, ahead of the division’s 2023 spin off as a separate company.

The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

China’s leading medical device company enters the orthopedic market with a $35.5 million acquisition of domestic player Dragonbio.